141 related articles for article (PubMed ID: 27176768)
1. Diosmetin induces apoptosis by upregulating p53 via the TGF-β signal pathway in HepG2 hepatoma cells.
Liu B; Shi Y; Peng W; Zhang Q; Liu J; Chen N; Zhu R
Mol Med Rep; 2016 Jul; 14(1):159-64. PubMed ID: 27176768
[TBL] [Abstract][Full Text] [Related]
2. Galangin suppresses HepG2 cell proliferation by activating the TGF-β receptor/Smad pathway.
Wang Y; Wu J; Lin B; Li X; Zhang H; Ding H; Chen X; Lan L; Luo H
Toxicology; 2014 Dec; 326():9-17. PubMed ID: 25268046
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the effects of the water-soluble total flavonoids from Isodon lophanthoides var.gerardianus (Benth.) H. Hara on apoptosis in HepG2 cell: Investigation of the most relevant mechanisms.
Feng CP; Tang HM; Huang S; Hou SZ; Liang J; Huang W; Lai XP
J Ethnopharmacol; 2016 Jul; 188():70-9. PubMed ID: 27132715
[TBL] [Abstract][Full Text] [Related]
4. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
5. Diosmetin Induces Cell Apoptosis by Regulating CYP1A1/CYP1A2 Due to p53 Activation in HepG2 Cells.
Liu B; Jia K; Yang Y; Hao S; Lu C; Xu F; Feng D; Zhu R
Protein Pept Lett; 2017 May; 24(5):406-412. PubMed ID: 28245756
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibition of luteolin on HepG2 cells is induced via p53 and Fas/Fas-ligand besides the TGF-β pathway.
Yee SB; Choi HJ; Chung SW; Park DH; Sung B; Chung HY; Kim ND
Int J Oncol; 2015 Aug; 47(2):747-54. PubMed ID: 26096942
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin induces growth inhibition and apoptosis in HepG2 and Huh7 hepatocellular carcinoma cells via upregulation of Notch1 expression.
Huang X; Ma J; Xu J; Su Q; Zhao J
Mol Med Rep; 2015 Mar; 11(3):2334-40. PubMed ID: 25412322
[TBL] [Abstract][Full Text] [Related]
8. Dihydromyricetin induces mouse hepatoma Hepal-6 cell apoptosis via the transforming growth factor-β pathway.
Liu B; Zhou W; Chen X; Xu F; Chen Y; Liu J; Zhang Q; Bao S; Chen N; Li M; Zhu R
Mol Med Rep; 2015 Mar; 11(3):1609-14. PubMed ID: 25376731
[TBL] [Abstract][Full Text] [Related]
9. NCPMF-60 induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells.
Dai QS; Liu W; Wang XB; Lu N; Gong DD; Kong LY; Guo QL
Anticancer Drugs; 2011 Jan; 22(1):46-57. PubMed ID: 20948430
[TBL] [Abstract][Full Text] [Related]
10. The p53-inducible gene 3 involved in flavonoid-induced cytotoxicity through the reactive oxygen species-mediated mitochondrial apoptotic pathway in human hepatoma cells.
Zhang Q; Cheng G; Qiu H; Zhu L; Ren Z; Zhao W; Zhang T; Liu L
Food Funct; 2015 May; 6(5):1518-25. PubMed ID: 25820747
[TBL] [Abstract][Full Text] [Related]
11. Diosmetin, a Potential p53 Activator, Performs Anticancer Effect by Regulating Cell Cycling and Cell Proliferation in HepG2 Cells.
Liu B; Zhang M; Liu S; Ying J; Zhang J; Kurihara H; Zheng W; He RR; Zhu R
Protein Pept Lett; 2017; 24(5):413-418. PubMed ID: 28240165
[TBL] [Abstract][Full Text] [Related]
12. Anticancer effect of xanthohumol induces growth inhibition and apoptosis of human liver cancer through NF-κB/p53-apoptosis signaling pathway.
Zhao X; Jiang K; Liang B; Huang X
Oncol Rep; 2016 Feb; 35(2):669-75. PubMed ID: 26718026
[TBL] [Abstract][Full Text] [Related]
13. The flavonoids diosmetin and luteolin exert synergistic cytostatic effects in human hepatoma HepG2 cells via CYP1A-catalyzed metabolism, activation of JNK and ERK and P53/P21 up-regulation.
Androutsopoulos VP; Spandidos DA
J Nutr Biochem; 2013 Feb; 24(2):496-504. PubMed ID: 22749133
[TBL] [Abstract][Full Text] [Related]
14. Dihydromyricetin Reduces TGF-β Via P53 Activation-dependent Mechanism in Hepatocellular Carcinoma HepG2 Cells.
Huang X; Lian T; Guan X; Liu B; Hao S; Zhang J; Bao S; Tan X; Zhu R
Protein Pept Lett; 2017; 24(5):419-424. PubMed ID: 28240161
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Apoptosis by SYB in HepG2 Liver Cancer Cells is Mediated by the P53/Caspase 9 Axis.
Sharula ; Wu Z
Anticancer Agents Med Chem; 2017; 17(7):941-947. PubMed ID: 28356025
[TBL] [Abstract][Full Text] [Related]
16. Amphiregulin impairs apoptosis-stimulating protein 2 of p53 overexpression-induced apoptosis in hepatoma cells.
Liu K; Lin D; Ouyang Y; Pang L; Guo X; Wang S; Zang Y; Chen D
Tumour Biol; 2017 Mar; 39(3):1010428317695026. PubMed ID: 28351301
[TBL] [Abstract][Full Text] [Related]
17. S-allylmercaptocysteine promotes MAPK inhibitor-induced apoptosis by activating the TGF-β signaling pathway in cancer cells.
Tong D; Qu H; Meng X; Jiang Y; Liu D; Ye S; Chen H; Jin Y; Fu S; Geng J
Oncol Rep; 2014 Sep; 32(3):1124-32. PubMed ID: 24970681
[TBL] [Abstract][Full Text] [Related]
18. Guggulsterone induces apoptosis of human hepatocellular carcinoma cells through intrinsic mitochondrial pathway.
Shi JJ; Jia XL; Li M; Yang N; Li YP; Zhang X; Gao N; Dang SS
World J Gastroenterol; 2015 Dec; 21(47):13277-87. PubMed ID: 26715810
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis of human hepatoma cell lines induced by transforming growth factor beta 1 (TGF-beta1) correlates with p53 and Smad4 activation.
Wang CL; Wan YL; Liu YC; Huang ZQ
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 38(2):176-8. PubMed ID: 16617361
[TBL] [Abstract][Full Text] [Related]
20. Anticarcinogenic action of quercetin by downregulation of phosphatidylinositol 3-kinase (PI3K) and protein kinase C (PKC) via induction of p53 in hepatocellular carcinoma (HepG2) cell line.
Maurya AK; Vinayak M
Mol Biol Rep; 2015 Sep; 42(9):1419-29. PubMed ID: 26311153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
